Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.601
-0.013 (-2.14%)
Mar 6, 2026, 10:05 AM EST - Market open
Vistagen Therapeutics Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 0.79 | 0.49 | 1.06 | -0.23 | 1.11 | 1.09 | Upgrade
|
| Revenue Growth (YoY) | 13.04% | -54.32% | - | - | 1.78% | - | Upgrade
|
| Gross Profit | 0.79 | 0.49 | 1.06 | -0.23 | 1.11 | 1.09 | Upgrade
|
| Selling, General & Admin | 18.57 | 17.08 | 14.06 | 14.66 | 13.96 | 7.64 | Upgrade
|
| Research & Development | 52.12 | 39.38 | 20.02 | 44.38 | 34.92 | 11.38 | Upgrade
|
| Operating Expenses | 70.69 | 56.46 | 34.09 | 59.04 | 48.89 | 19.02 | Upgrade
|
| Operating Income | -69.9 | -55.97 | -33.02 | -59.27 | -47.78 | -17.93 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0.01 | Upgrade
|
| Interest & Investment Income | 2.84 | 4.56 | 3.35 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0.31 | - | - | 0 | Upgrade
|
| EBT Excluding Unusual Items | -67.05 | -51.41 | -29.36 | -59.24 | -47.76 | -17.93 | Upgrade
|
| Pretax Income | -67.05 | -51.41 | -29.36 | -59.24 | -47.76 | -17.93 | Upgrade
|
| Income Tax Expense | - | 0.01 | 0 | 0.01 | 0 | 0 | Upgrade
|
| Net Income | -67.05 | -51.42 | -29.36 | -59.25 | -47.76 | -17.93 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.95 | 24.39 | Upgrade
|
| Net Income to Common | -67.05 | -51.42 | -29.36 | -59.25 | -48.71 | -42.32 | Upgrade
|
| Shares Outstanding (Basic) | 35 | 31 | 19 | 7 | 7 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 35 | 31 | 19 | 7 | 7 | 3 | Upgrade
|
| Shares Change (YoY) | 15.56% | 59.53% | 178.13% | 5.45% | 129.85% | 96.34% | Upgrade
|
| EPS (Basic) | -1.89 | -1.67 | -1.52 | -8.51 | -7.38 | -14.74 | Upgrade
|
| EPS (Diluted) | -1.89 | -1.67 | -1.52 | -8.51 | -7.38 | -14.74 | Upgrade
|
| Free Cash Flow | -60.54 | -42.29 | -25.87 | -49.93 | -45.46 | -12.35 | Upgrade
|
| Free Cash Flow Per Share | -1.71 | -1.37 | -1.34 | -7.17 | -6.89 | -4.30 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | - | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -8859.82% | -11517.08% | -3103.48% | - | -4308.68% | -1646.06% | Upgrade
|
| Profit Margin | -8497.59% | -10579.83% | -2759.59% | - | -4392.42% | -3884.33% | Upgrade
|
| Free Cash Flow Margin | -7672.62% | -8701.24% | -2431.77% | - | -4099.28% | -1133.45% | Upgrade
|
| EBITDA | -69.72 | -55.82 | -32.89 | -59.14 | -47.63 | -17.82 | Upgrade
|
| D&A For EBITDA | 0.19 | 0.15 | 0.13 | 0.13 | 0.15 | 0.12 | Upgrade
|
| EBIT | -69.9 | -55.97 | -33.02 | -59.27 | -47.78 | -17.93 | Upgrade
|
| Revenue as Reported | 0.79 | 0.49 | 1.06 | -0.23 | 1.11 | 1.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.